Lifecore Biomedical, Inc. \De\ Income Statement (2010-2025) | LFCR

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Aug2020	Nov2020	Feb2021	May2021	Aug2021	Nov2021	Feb2022	May2022	Aug2022	Nov2022	Feb2023	May2023	Aug2023	Nov2023	Feb2024	May2024	Aug2024	Nov2024	Feb2025	May2025
Revenue & cost
Revenue (Quarter)	22.68M	23.79M	27.81M	44.92M	22.33M	25.60M	35.23M	28.11M	23.72M	21.86M	26.54M	31.14M	24.52M	30.15M	35.70M	37.89M	24.70M	32.56M	35.15M	36.44M
Cost of Revenue (Quarter)	17.38M	13.02M	16.88M	-30.15M	16.79M	14.14M	23.59M	17.68M	17.75M	16.18M	17.99M	23.37M	21.79M	20.19M	23.81M	20.61M	19.32M	21.48M	25.31M	22.46M
Gross Profit (Quarter)	5.29M	10.77M	10.93M	14.58M	5.54M	11.46M	11.64M	10.42M	5.98M	5.68M	8.55M	7.78M	2.73M	9.96M	11.89M	17.27M	5.39M	11.08M	9.85M	13.98M
Operating items
Research & Development (Quarter)	1.74M	1.59M	1.64M	6.68M	1.69M	1.68M	2.25M	7.76M	2.21M	2.18M	2.23M	2.12M	2.15M	2.10M	2.17M	2.16M	2.19M	1.92M	2.04M	2.10M
Selling, General & Administrative (Quarter)	7.49M	6.71M	7.15M	19.76M	6.95M	5.46M	13.75M	32.95M	8.10M	8.29M	10.28M	12.29M	9.20M	9.34M	9.85M	12.23M	14.79M	11.12M	9.98M	8.98M
Restructuring Costs (Quarter)	6.67M	1.10M	2.07M	13.36M	1.13M	0.63M	5.27M	1.33M	1.05M	0.56M	2.57M	0.01M	-0.01M	0.16M	0.77M	0.74M			-0.12M	-2.52M
Other Operating Expenses (Quarter)				-36.71M				-30.00M			-20.70M	-0.30M	0.20M	20.70M	21.00M	-2.40M	0.90M	1.20M	-0.60M	-1.09M
Operating Expenses (Quarter)	15.90M	9.40M	10.86M	3.09M	9.77M	7.77M	21.28M	12.04M	9.25M	11.03M	15.08M	14.42M	11.34M	11.44M	12.79M	15.12M	16.97M	13.04M	11.91M	8.56M
Operating Income (Quarter)	-10.60M	1.37M	0.07M	-6.63M	-4.22M	3.69M	-9.64M	-2.51M	-3.27M	-5.35M	-6.53M	-6.64M	-8.61M	-1.48M	-0.90M	2.15M	-11.58M	-1.96M	-9.03M	5.33M
EBIT (Quarter)	-10.60M	1.37M	0.07M	-6.63M	-4.22M	3.69M	-9.64M	-2.51M	-3.27M	-5.35M	-6.53M	-6.64M	-8.61M	-1.48M	-0.90M	2.15M	-11.58M	-1.96M	-9.03M	5.33M
Non-operating items
Interest & Investment Income (Quarter)		0.01M	0.01M	0.02M	0.03M	0.02M	0.02M	0.02M	0.01M	0.02M	0.02M	0.02M			-0.92M	-12.12M	0.01M		0.11M	-5.12M
Other Non Operating Income (Quarter)	-1.52M	-9.71M	0.30M	-10.97M	0.05M	0.33M	0.29M	-0.02M	-0.20M	-0.24M	0.10M	-23.37M	-0.17M	-0.97M	-0.81M	-1.10M	-0.20M	-0.30M	0.33M	0.17M
Non Operating Income (Quarter)	-1.52M	-9.71M	0.30M	-10.97M	0.05M	0.33M	0.29M	0.74M	-0.20M	-0.24M	0.10M	-0.83M	-0.17M	-0.97M	-0.81M	-1.10M	-0.20M	-0.30M	0.33M	0.17M
Net income details
EBT (Quarter)	-13.78M	-9.92M	-3.28M	-19.97M	-10.28M	1.27M	-7.53M	-4.15M	-6.70M	-9.20M	-11.26M	-36.77M	-12.52M	14.18M	15.00M	-7.14M	-16.25M	-6.53M	-14.78M	-1.11M
Tax Provisions (Quarter)	-3.79M	-1.53M	-1.53M	-9.42M	-1.81M	-6.28M	3.39M	-9.60M	0.00M	0.00M	0.07M	0.23M	0.09M	-0.07M	0.22M	-0.06M	-0.03M	0.04M	-0.01M	0.03M
Profit After Tax (Quarter)	-9.99M	-11.62M	-1.75M	-0.78M	-8.47M	7.55M	-13.59M	-3.63M	-6.71M	-12.81M	-36.51M	-37.00M	-10.75M	14.22M	15.63M	-9.77M	-16.23M	-6.57M	-14.77M	-1.15M
Income from Non-Controlling Interests (Quarter)
Income from Continuing Operations (Quarter)	-9.99M	-8.39M	-1.75M	-10.56M	-8.47M	7.55M	-10.92M	5.45M	-6.71M	-9.20M	-11.33M	-37.00M	-12.61M	14.24M	14.79M	-7.09M	-16.23M	-6.57M	-14.77M	-1.15M
Consolidated Net Income (Quarter)	-3.24M	-3.23M	-5.23M	-2.08M	-1.20M	-46.02M	-2.67M	-51.64M	-4.26M	-3.60M	-25.18M	-2.29M	1.85M	-0.02M	0.85M	0.00M
Income towards Parent Company (Quarter)	-3.24M	-3.23M	-5.23M	-2.08M	-1.20M	-46.02M	-2.67M	-51.64M	-4.26M	-3.60M	-25.18M	-2.29M	1.85M	-0.02M	0.85M	0.00M
Preferred Dividend Payments (Quarter)																			0.84M	0.05M
Net Income towards Common Stockholders (Quarter)	-3.24M	-3.23M	-5.23M	-2.08M	-1.20M	-46.02M	-2.67M	-51.64M	-4.26M	-3.60M	-25.18M	-2.29M	1.85M	14.22M	15.63M	-7.08M	-16.23M	-8.70M	-15.65M	-2.05M
Additional items
EPS (Basic) (Quarter)	-0.42	-0.40	-0.24	-0.03	-0.32	-1.31	-0.37	-1.88	-0.37	-0.31	-0.37	-1.23	-0.41	0.47	0.51	-0.33	-0.53	-0.25	-0.42	-0.03
EPS (Weighted Average and Diluted) (Quarter)	-0.42	-0.40	-0.24	-0.03	-0.32	-1.31	-0.37	-1.88	-0.23	-0.31	-1.20	-1.32	-0.35	0.39	0.40	-0.19	-0.53	-0.25	-0.42	-0.03
Shares Outstanding (Weighted Average) (Quarter)	29.24M	29.28M	29.28M	29.29M	29.42M	29.47M	29.48M	29.47M	29.58M	29.63M	30.30M	29.96M	30.40M	30.43M	30.45M	30.47M	30.86M	34.36M	37.02M	34.82M
Shares Outstanding (Diluted Average) (Quarter)	29.24M	29.28M	29.32M	29.29M	29.42M	29.47M	29.48M	29.47M	29.58M	29.63M	30.30M	29.96M	30.40M	36.42M	36.47M	36.66M	30.86M	34.36M	37.02M	34.82M
EBITDA (Quarter)	-10.70M	-12.90M	-5.11M	-6.63M	-9.11M	-38.27M	-12.98M	-2.51M	-10.67M	-12.52M	-36.51M	-6.64M	-10.75M	14.22M	15.63M	2.15M	-11.58M	-1.96M	-9.03M	5.33M
Interest Expenses (Quarter)	1.67M	1.60M	2.56M	2.32M	6.13M	2.77M	3.68M	-12.57M		3.61M	4.83M	0.35M	3.15M	3.24M	3.37M	12.12M	4.40M	4.62M	4.84M
Tax Rate (Quarter)	27.49%	15.41%	46.63%	47.14%	17.58%	-493.32%	-45.00%	231.49%	-0.06%	-0.04%	-0.62%	-0.63%	-0.70%	-0.46%	1.45%	0.80%	0.15%	-0.66%	0.05%	-2.96%

Research Tools

Lifecore Biomedical, Inc. \De\ Income Statement (2010-2025) | LFCR

Create an account

Sign In

Reset Password